Literature DB >> 8692873

Infectivity of chimeric human T-cell leukemia virus type I molecular clones assessed by naked DNA inoculation.

T M Zhao1, M A Robinson, F S Bowers, T J Kindt.   

Abstract

Two human T-cell leukemia virus type I (HTLV-I) molecular clones, K30p and K34p were derived from HTLV-I-infected rabbit cell lines. K30p and K34p differ by 18 bp with changes in the long terminal repeats (LTRs) as well as in the gag, pol, and rex but not tax or env gene products. Cells transfected with clone K30p were infectious in vitro and injection of the K30p transfectants or naked K30p DNA into rabbits leads to chronic infection. In contrast, K34p did not mediate infection in vitro or in vivo, although the cell line from which it was derived is fully infectious and K34p transfectants produce intact virus particles. To localize differences involved in the ability of the clones to cause infection, six chimeric HTLV-I clones were constructed by shuffling corresponding fragments containing the substitutions in the LTRs, the gag/pol region and the rex region between K30p and K34p. Cells transfected with any of the six chimeras produced virus, but higher levels of virus were produced by cells transfected with those constructs containing the K30p rex region. Virus production was transient except in cells transfected with K30p or with a chimera consisting of the entire protein coding region of K30p flanked by K34p LTRs; only the transfectants showing persistent virus production mediated in vitro infection. In vivo infection in rabbits following intramuscular DNA injection was mediated by K30p as well as by a chimera of K30p containing the K34p rex gene. Comparisons revealed that virus production was greater and appeared earlier in rabbits injected with K30p. These data suggest that several defects in the K34p clone preclude infectivity and furthermore, provide systems to explore functions of HTLV-I genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8692873      PMCID: PMC39081          DOI: 10.1073/pnas.93.13.6653

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

2.  Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I.

Authors:  I J Koralnik; A Gessain; M E Klotman; A Lo Monico; Z N Berneman; G Franchini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 3.  Neurological disorders associated with HTLV-1.

Authors:  D E McFarlin; H Koprowski
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Gene inoculation generates immune responses against human immunodeficiency virus type 1.

Authors:  B Wang; K E Ugen; V Srikantan; M G Agadjanyan; K Dang; Y Refaeli; A I Sato; J Boyer; W V Williams; D B Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  Variation in HTLV-I sequences from rabbit cell lines with diverse in vivo effects.

Authors:  T M Zhao; M A Robinson; S Sawasdikosol; R M Simpson; T J Kindt
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

6.  Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells.

Authors:  D Derse; J Mikovits; M Polianova; B K Felber; F Ruscetti
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

7.  Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones.

Authors:  J T Kimata; F H Wong; J J Wang; L Ratner
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

8.  Seronegative virus carriers in the infection of rabbits with human T lymphotropic virus type I.

Authors:  A Seto; M Kawanishi; S Matsuda; K Ogawa
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

Review 9.  Human T cell lymphotropic virus type I and cutaneous T cell leukemia/lymphoma.

Authors:  W W Hall
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

10.  Selection of rabbit CD4- CD8- T cell receptor-gamma/delta cells by in vitro transformation with human T lymphotropic virus-I.

Authors:  S Sawasdikosol; B F Hague; T M Zhao; F S Bowers; R M Simpson; M Robinson; T J Kindt
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  4 in total

1.  Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.

Authors:  J C Twizere; P Kerkhofs; A Burny; D Portetelle; R Kettmann; L Willems
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Genes in the pX region of human T cell leukemia virus I influence Vav phosphorylation in T cells.

Authors:  W Mahana; T M Zhao; R Teller; M A Robinson; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

3.  Quantification of HTLV-I proviral load in experimentally infected rabbits.

Authors:  Tong-Mao Zhao; Bishop Hague; David L Caudell; R Mark Simpson; Thomas J Kindt
Journal:  Retrovirology       Date:  2005-05-23       Impact factor: 4.602

4.  Use of synthetic single-stranded oligonucleotides as artificial test soiling for validation of surgical instrument cleaning processes.

Authors:  Nadja Wilhelm; Nadja Perle; Robert Simmoteit; Christian Schlensak; Hans P Wendel; Meltem Avci-Adali
Journal:  Biomed Res Int       Date:  2014-02-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.